Holland Capital has sold Quantib to RadNet
Quantib B.V., a portfolio company of Holland Capital, has been sold to RadNet, Inc.
Founded in 2012 and headquartered in the Netherlands, Quantib is a leading radiology artificial intelligence and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.
RadNet is a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers in the USA.
Holland Capital is one of the first independent private equity firms in the Netherlands. Since 1981, they have been successfully and responsibly investing in promising small and medium-sized Dutch businesses with growth ambitions. With a clear investment strategy, they anticipate long-term trends in attractive growth markets, focusing on the healthcare and technology sectors. Their experienced and dedicated investment team knows what entrepreneurship is.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to Quantib B.V.
Talk to the deal team
James McLaren
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
Michael L. Bauman
Oaklins TM Capital
Harrison P. Boeschenstein
Oaklins TM Capital
Related deals
Zephyr Group has acquired PK OEM Parts
Zephyr Group has acquired PK OEM Parts. With the entry of PK OEM Parts, Zephyr Group aims to achieve a consolidated turnover of approximately US$65 million in 2023. The acquisition will allow an increase in the services and product range offered to customers by leveraging the group’s know-how and logistical capabilities. Furthermore, the acquisition represents a step forward in the growth and consolidation strategy that Zephyr Group started in 2018 with the acquisition of Spanish competitor SKV.
Learn moreBaird Capital invests in Freemarket
Baird Capital has completed a growth capital investment in Freemarket. The investment supports Freemarket’s continuing fast growth and international expansion, as well as providing a partial cash-out to existing shareholders.
Learn moreStrahinjcica has been acquired by Studenac
The owner of Strahinjcica has sold the company to Studenac.
Learn more